These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2283251)

  • 21. [Use of Omniscan (gadodiamide) in magnetic resonance studies of the central nervous system (results of a multicenter study)].
    Sinitsyn VE; Kornienko VN; Nikitin VG; Pronin IN; Ternovoĭ SK; Tiutin LA; Iakobson MG
    Vestn Rentgenol Radiol; 1995; (4):5-11. PubMed ID: 8571538
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of contrast media for magnetic resonance imaging.
    Goldstein HA; Wiggins JR; Kashanian F
    Ann N Y Acad Sci; 1992 Mar; 649():322-31. PubMed ID: 1580503
    [No Abstract]   [Full Text] [Related]  

  • 23. Safety of gadodiamide injection in two different age groups.
    Högström B; Kristoffersen DT; Lundby B; Svaland MG
    J Magn Reson Imaging; 1996; 6(1):255-7. PubMed ID: 8851438
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Artificial contrasting during magnetic resonance tomography].
    Sergeev PV; Panov OV; Egorova SV; Bolotova EN; Shimanovskii NL; Akhadov TA; Sviridov NK
    Vestn Rentgenol Radiol; 1997; (1):45-52. PubMed ID: 9133071
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparison of the safety of standard and triple dose gadodiamide injection in MR imaging of the central nervous system. A double-blind study.
    Svaland MG; Christensen T; Lundorf E
    Acta Radiol; 1994 Jul; 35(4):396-9. PubMed ID: 8011392
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Anaphylactoid reaction caused by intravenous gadopentetate dimeglumine in magnetic resonance].
    Campos A; Aznar L; Alamar R; Castelló JV
    Med Clin (Barc); 1996 Feb; 106(5):197. PubMed ID: 8684023
    [No Abstract]   [Full Text] [Related]  

  • 27. Gadodiamide injection and gadopentetate dimeglumine. A double-blind study in MR imaging of the CNS.
    Myhr G; Rinck PA; Børseth A
    Acta Radiol; 1992 Sep; 33(5):405-9. PubMed ID: 1389644
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Considerations in the choice of contrast media for MR imaging.
    Brasch RC; Bennett HF
    Radiology; 1988 Mar; 166(3):897-9. PubMed ID: 3340795
    [No Abstract]   [Full Text] [Related]  

  • 29. [Gadolinium-DTPA dimeglumine administered orally for the study of the abdomen with magnetic resonance. Clinical evaluation and tolerance].
    Squillaci E; Crecco M; Cecconi L; Lupoi D; Sergiacomi GL; Simonetti G
    Radiol Med; 1993 Sep; 86(3):284-93. PubMed ID: 8210538
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the safety of the standard dose and a higher dose of gadodiamide injection for MR imaging of the central nervous system.
    Svaland MG; Lundby B; Kristoffersen DT
    J Magn Reson Imaging; 1994; 4(3):419-23. PubMed ID: 8061442
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preliminary clinical trial of gadodiamide injection: a new nonionic gadolinium contrast agent for MR imaging.
    Kaplan GD; Aisen AM; Aravapalli SR
    J Magn Reson Imaging; 1991; 1(1):57-62. PubMed ID: 1802131
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Oral contrast media for the magnetic resonance tomography of the abdomen. A clinical trial of the tolerance for gadolinium-DTPA].
    Kaminsky S; Laniado M; Gogoll M; Kornmesser W; Clauss W; Felix R
    Rofo; 1992 Jan; 156(1):17-23. PubMed ID: 1733470
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fatal reaction to gadopentetate dimeglumine.
    Jordan RM; Mintz RD
    AJR Am J Roentgenol; 1995 Mar; 164(3):743-4. PubMed ID: 7863905
    [No Abstract]   [Full Text] [Related]  

  • 34. Case of anaphylaxis and four cases of allergic reaction following Gd-DTPA administration.
    Salonen OL
    J Comput Assist Tomogr; 1990; 14(6):912-3. PubMed ID: 2229566
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kinetics and magnetic resonance imaging of Gd-EOB-DTPA in dogs.
    Benness G; Khangure M; Morris I; Warwick A; Burrows P; Vogler H
    Invest Radiol; 1994 Jun; 29 Suppl 2():S177-8. PubMed ID: 7928221
    [No Abstract]   [Full Text] [Related]  

  • 36. MRI in children given gadodiamide injection: safety and efficacy in CNS and body indications.
    Lundby B; Gordon P; Hugo F
    Eur J Radiol; 1996 Nov; 23(3):190-6. PubMed ID: 9003923
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative pharmacokinetics of gadolinium DTPA and gadolinium chloride.
    Dean PB; Niemi P; Kivisaari L; Kormano M
    Invest Radiol; 1988 Sep; 23 Suppl 1():S258-60. PubMed ID: 3198357
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pharmacokinetics of gadolinium-DTPA in chronic renal insufficiency requiring dialysis].
    Krahe T; Götz R; Lackner K; Haustein J; Klemenz U; Landwehr P; Heidbreder E; Schuhmann-Giampieri G
    Rofo; 1992 Jun; 156(6):523-6. PubMed ID: 1617171
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute deterioration of myasthenia gravis after intravenous administration of gadolinium-DTPA.
    Nordenbo AM; Somnier FE
    Lancet; 1992 Nov; 340(8828):1168. PubMed ID: 1359250
    [No Abstract]   [Full Text] [Related]  

  • 40. Pharmacokinetics of the liver-specific contrast agent Gd-EOB-DTPA in relation to contrast-enhanced liver imaging in humans.
    Schuhmann-Giampieri G; Mahler M; Röll G; Maibauer R; Schmitz S
    J Clin Pharmacol; 1997 Jul; 37(7):587-96. PubMed ID: 9243351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.